Former President and Chief Financial Officer · Cogent Biosciences, Inc. (COGT)

Christiana Stamoulis

A named executive officer of Cogent Biosciences in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,031,995

Salary $409,300

FY2017: $954,557

3rd of 4 named executive officers at Cogent Biosciences by FY2018 total.

4 named officers on file for Cogent Biosciences, FY2018

Christiana Stamoulis’s pay file — $29

  • 2 fiscal years of pay, line by line
  • COGT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cogent Biosciences’s whole pay program stands against its peers

  • Cogent Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COGT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2019 (DEF 14A).

Free

Get Christiana Stamoulis’s full pay file as a PDF — free

More than this page: up to 10 years of Christiana’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Christiana Stamoulis compensation by year

Cogent Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Cogent Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$348,750$409,300
Bonus$132,300—
Stock awards$0—
Option awards$473,507$606,995
Non-equity incentive$0—
Pension and deferred compensation$0—
All other$0—
Total$954,557$1,031,995

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cogent Biosciences, Inc. DEF 14A filed April 30, 2019, accession 0001193125-19-129799, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cogent Biosciences, Inc. filed document, accession 0001193125-19-129799. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.

$955K
$1.0M
FY17
FY18
SalaryBonusOption awards

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option8,293—$0.18
Option12,771—$0.18
Option56,391—$9.77
Option96,577—$12.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Cogent Biosciences, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Cogent Biosciences’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Charles WilsonChief Executive Officer$2,117,115
Michael VasconcellesChief Medical Officer$1,070,003
Christiana Stamoulis · this pageFormer President and Chief Financial Officer$1,031,995
Seth EttenbergFormer Chief Scientific Officer$978,485

The full Cogent Biosciences compensation record

free company brief

This page is one person within Cogent Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cogent Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cogent Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Christiana Stamoulis's compensation dossier · One-time report. No refunds.